| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.078 | 0.08 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.08 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.3 | 0.09 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.068 | 0.09 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.32 | 0.09 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.057 | 0.09 |